Ingevity (NGVT) Capital Expenditures (2015 - 2026)

Ingevity (NGVT) has 12 years of Capital Expenditures data on file, last reported at $10.3 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $10.3 million, up 255.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.9 million (up 1.39% YoY), and the FY2025 annual result was $1.7 million, down 29.17% from the prior year.
• Capital Expenditures improved to $10.3 million in Q1 2026 per NGVT's latest filing, from $100000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $51.9 million in Q2 2022 and troughed at -$52.1 million in Q3 2022.
• A 5-year average of $10.3 million and a median of $10.3 million in 2026 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 1960.71% in 2022, then surged 14700.0% in 2023.
• A 5-year view of Capital Expenditures shows it stood at -$200000.0 in 2022, then surged by 14700.0% to $29.2 million in 2023, then slumped by 99.32% to $200000.0 in 2024, then sank by 50.0% to $100000.0 in 2025, then surged by 10200.0% to $10.3 million in 2026.
• Business Quant data shows NGVT's Capital Expenditures at $10.3 million in Q1 2026, $100000.0 in Q4 2025, and -$700000.0 in Q3 2025.